JF
Jump Financial Portfolio holdings
AUM
$8.14B
1-Year Return
18.67%
This Quarter Return
+5.18%
1 Year Return
+18.67%
3 Year Return
+54.31%
5 Year Return
+107.56%
10 Year Return
–
AUM
$1.59B
AUM Growth
+$209M
(+15%)
Cap. Flow
+$131M
Cap. Flow
% of AUM
8.23%
Top 10 Holdings %
Top 10 Hldgs %
18.94%
Holding
1,885
New
839
Increased
299
Reduced
192
Closed
550
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$42.2M |
| 2 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$19.2M |
| 3 |
Apple
AAPL
|
+$14.3M |
| 4 |
Microsoft
MSFT
|
+$13.7M |
| 5 |
iShares Silver Trust
SLV
|
+$11.6M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$89.1M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$70.4M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$56M |
| 4 |
Direxion Daily S&P 500 Bull 3x Shares
SPXL
|
+$51.3M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$31.4M |
Sector Composition
| 1 | Technology | 18.39% |
| 2 | Healthcare | 12.38% |
| 3 | Consumer Discretionary | 9.64% |
| 4 | Financials | 8.03% |
| 5 | Industrials | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
676
Alaska Air
ALK
$7.21B
| $474K | 0.03% |
+9,100
| New | +$474K |
|
677
ATAI Life Sciences
ATAI
$973M
| $472K | 0.03% |
+61,800
| New | +$472K |
|
|
DSKE
678
DELISTED
Daseke, Inc. Common Stock
DSKE
| $471K | 0.03% |
46,961
-14,900
| -24% | -$149K |
|
679
United Therapeutics
UTHR
$18B
| $470K | 0.03% |
2,173
-14,659
| -87% | -$3.17M |
|
680
Innoviz Technologies
INVZ
$373M
| $468K | 0.03% |
+73,934
| New | +$468K |
|
681
La-Z-Boy
LZB
$1.44B
| $468K | 0.03% |
+12,900
| New | +$468K |
|
|
TRTX
682
TPG RE Finance Trust
TRTX
$751M
| $468K | 0.03% |
+37,961
| New | +$468K |
|
683
Aclaris Therapeutics
ACRS
$225M
| $465K | 0.03% |
+32,000
| New | +$465K |
|
684
Annexon
ANNX
$273M
| $464K | 0.03% |
+40,397
| New | +$464K |
|
685
Forrester Research
FORR
$190M
| $464K | 0.03% |
7,900
+1,600
| +25% | +$94K |
|
686
Safe Bulkers
SB
$451M
| $464K | 0.03% |
123,000
-15,961
| -11% | -$60.2K |
|
687
Advanced Drainage Systems
WMS
$11.3B
| $463K | 0.03% |
+3,400
| New | +$463K |
|
688
BioCryst Pharmaceuticals
BCRX
$1.69B
| $461K | 0.03% |
+33,300
| New | +$461K |
|
689
Lindsay Corp
LNN
$1.52B
| $461K | 0.03% |
+3,035
| New | +$461K |
|
690
Otis Worldwide
OTIS
$34.9B
| $461K | 0.03% |
+5,300
| New | +$461K |
|
691
AudioCodes
AUDC
$294M
| $459K | 0.03% |
+13,200
| New | +$459K |
|
692
Prelude Therapeutics
PRLD
$68.5M
| $459K | 0.03% |
+36,900
| New | +$459K |
|
693
JD.com
JD
$48.1B
| $457K | 0.03% |
+6,521
| New | +$457K |
|
694
Denali Therapeutics
DNLI
$2.17B
| $455K | 0.03% |
+10,203
| New | +$455K |
|
695
Sarepta Therapeutics
SRPT
$1.8B
| $455K | 0.03% |
+5,055
| New | +$455K |
|
696
Verint Systems
VRNT
$1.23B
| $455K | 0.03% |
+8,654
| New | +$455K |
|
697
Ecovyst
ECVT
$1.09B
| $453K | 0.03% |
+44,200
| New | +$453K |
|
698
EverQuote
EVER
$871M
| $453K | 0.03% |
28,900
-700
| -2% | -$11K |
|
699
Mersana Therapeutics
MRSN
$37.1M
| $453K | 0.03% |
+2,916
| New | +$453K |
|
700
Carlyle Secured Lending
CGBD
$999M
| $452K | 0.03% |
+32,900
| New | +$452K |
|